DCM Shriram Inds (DCMSRIND)
CyclicalScore breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 1/1
Key Financials
| Current Price | ₹42.24 |
| Market Cap | ₹367.46 Cr |
| P/E Ratio | 16.06 |
| ROCE | 13.73% |
| ROE | 6.59% |
| Dividend Yield | 0.95% |
| Profit Growth | -91.29% |
| Debt/Equity | 1.17 |
| Sales Growth | -40.25% |
| Promoter Holding | 50.11% |
| 52-Week Range | ₹31.9 — ₹181.9 |
| Sector | Agricultural Food & other Products |
| Book Value | ₹41.93 |
Strengths
- Trades at 0.41x book value with book value of ₹99.11, providing asset-backing cushion
- Promoter holding of 50.11% aligns management with minority shareholders
- Debt/equity of 0.33 is moderate, and ROCE of 13.73% shows acceptable capital efficiency
- Dividend yield of 5.51% offers cash return while waiting for a cyclical recovery
Concerns
- Profit growth down 113.62% and latest quarter net loss of ₹3 crore raise doubt on earnings power
- ROE of only 6.59% indicates weak returns on shareholders' equity
- Piotroski F-Score of 3/9 signals financial stress and deteriorating fundamentals
- Stock has crashed from 52-week high of ₹181.90 to ₹40.93, suggesting business deterioration may still be underway
AI Analysis
At ₹40.93, DCM Shriram Inds trades at 0.41 times book, but cheapness is only meaningful if earnings power is intact. The latest quarter shows sales of ₹527 crore and a net loss of ₹3 crore; profit growth collapsed by 113.62%. That is not the signature of a predictable compounding business. Sugar is a cyclical commodity, subject to cane prices and government policy. With promoter holding at 50.11%, interests are reasonably aligned, and debt/equity at 0.33 is manageable. ROCE of 13.73% is respectable, but ROE of only 6.59% means shareholders are not earning much on the growing asset base. The high dividend yield of 5.51% is attractive, but I need to be sure it can be maintained if quarterly losses persist. The 52-week range—₹31.90 to ₹181.90—tells me volatility is enormous; this is not a gentle stalwart. The Piotroski F-Score of 3/9 confirms weak financial health. I cannot call this a wonderful business. The trailing P/E of 7.78 is misleading if the latest quarter's negative profit is the new normal. Book value of ₹99.11 gives a theoretical cushion, but in a distressed commodity cycle, book values can erode. I would need evidence of normalized earnings—not just a low price-to-book—before committing capital. This looks like a cyclical or asset situation, but the margin of safety is real only if management can generate profits through the cycle. I would watch sugar prices, government policy, and whether the dividend is truly covered. If earnings stabilise, the stock could re-rate; if not, the low valuation is a value trap.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer